The global healthcare contract sales organizations market size is expected to reach USD 21.81 billion by 2033, registering a CAGR of 7.87% from 2025 to 2033, according to a new report by Grand View Research, Inc. High adoption of new technologies for contract sales by healthcare contract sales organizations, an increase in the interest among end users to maximize the sales of biopharmaceutical and small molecule drugs, a need for cost reduction associated with in-house sales, a rise in regulatory scrutiny, evolving provider habits, growing demand for personalized medicine, and increasing competition among healthcare companies are some of the key factors supporting the growth of the Healthcare Contract Sales Organizations market.
Pharmaceutical, biopharmaceutical, and MedTech companies are facing increasing complexity in managing their product portfolios and engaging with stakeholders due to the constant advancement of healthcare systems and technologies. The COVID-19 pandemic has also posed challenges in effectively engaging with healthcare professionals. To address these challenges, many companies are turning to contract sales organizations as outsourcing partners. CSOs offer dedicated services for various industries and provide flexibility in scaling sales forces up or down as needed. This strategic option is driving the growth of the healthcare contract sales organizations market and allowing companies to focus on development, performance, and growth while CSOs handle sales activities.
The healthcare contract sales organizations market is being driven by the adoption of the latest sales force automation solutions and omnichannel patient engagement. These technologies enable seamless communication between clients, sales representatives, and the field force, leading to increased efficiency and effectiveness in delivering services. As companies seek to maximize their sales and expand their businesses, CSOs are delivering services more effectively and efficiently with the help of these technological advancements. With the increasing demand for these solutions, the healthcare contract sales organizations market is expected to grow further in the coming years.
Request a free sample copy or view report summary: Healthcare Contract Sales Organizations Market Report
On the basis of service, the non-personal promotion segment held the largest revenue share of 53.27% in 2024 and is the fastest-growing segment over the forecast period.
Based on therapeutic area, oncology represented the largest segment in the market in 2024, due to the growing prevalence of cancer and the increasing complexity of oncology therapies.
The North America healthcare contract sales organizations industry dominated the market in 2024.
Grand View Research has segmented the global healthcare contract sales organizations market on the basis of service, therapeutic area, end use, and region:
Healthcare Contract Sales Organizations Service Outlook (Revenue, USD Million, 2021 - 2033)
Personal Promotion
Promotional sales team
Key account management
Vacancy Management
Non - Personal Promotion
Medical Affairs Solutions
Remote Medical Science Liaisons
Nurse (Clinical) Educators
Others
Healthcare Contract Sales Organizations Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
Oncology
Cardiovascular
Neurology
Infectious Diseases
Metabolic Disorders
Orthopedic Diseases
Others
Healthcare Contract Sales Organizations End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical companies
Biopharmaceutical companies
Medical device companies
Healthcare Contract Sales Organizations Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
UAE
Saudi Arabia
Kuwait
Qatar
Oman
List of Key Players in the Healthcare Contract Sales Organizations Market
CMIC HOLDINGS Co., LTD.
Axxelus
EPS Corporation.
IQVIA, Inc.
Publicis Group
MaBico
Syneos Health
"The quality of research they have done for us has been excellent..."